Hematologic Malignancy
Childhood B Lymphoblastic Lymphoma
CI-CAN-00002202Explore in graph →
PediatricHematologic
- NCIt
- C7209
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00002202Explore in graph →
Clinical trials
2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (0)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01700946 | Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma | completed | Phase 2 | 80 | St. Jude Children's Research HospitalOTHER | 1 | Sep 28, 2022 | clinicaltrials |
Data updated 22 days agoSource updated Sep 28, 2022source: clinicaltrials